Sandra Cavanah Tucher
Profile
Sandra Cavanah Tucher worked as the Chief Financial Officer at Open Monoclonal Technology, Inc.
Former positions of Sandra Cavanah Tucher
| Companies | Position | End |
|---|---|---|
Open Monoclonal Technology, Inc.
 Open Monoclonal Technology, Inc. BiotechnologyHealth Technology Open Monoclonal Technology, Inc. engages in the genetic engineering of animals for discovery of human therapeutic antibodies. The firm’s transgenic animal platforms include OmniRat, industry’s first human monoclonal antibody technology based on rats; OmniMouse, a transgenic mouse that complements OmniRat and expands epitope coverage and; OmniFlic, the first engineered rat with a fixed light chain for development of bispecific, fully human antibodies. The company was founded in by Roland Buelow 2007 and is headquartered in San Diego, CA. | Director of Finance/CFO | - |
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Private companies | 1 |
|---|---|
Open Monoclonal Technology, Inc.
Open Monoclonal Technology, Inc. BiotechnologyHealth Technology Open Monoclonal Technology, Inc. engages in the genetic engineering of animals for discovery of human therapeutic antibodies. The firm’s transgenic animal platforms include OmniRat, industry’s first human monoclonal antibody technology based on rats; OmniMouse, a transgenic mouse that complements OmniRat and expands epitope coverage and; OmniFlic, the first engineered rat with a fixed light chain for development of bispecific, fully human antibodies. The company was founded in by Roland Buelow 2007 and is headquartered in San Diego, CA. | Health Technology |
- Stock Market
- Insiders
- Sandra Cavanah Tucher
